We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




Hologic to Acquire Mammography Technology

By HospiMedica staff writers
Posted on 05 Jul 2005
Hologic (Bedford, MA, USA), a provider of diagnostic imaging and digital imaging systems geared toward women's health, has entered into a definitive agreement to acquire the intellectual property of Fischer Imaging Corp. (Denver, CO, USA) related to its mammography business and products, including the rights to its SenoScan digital mammography and MammoTest stereotactic breast biopsy systems. Fischer Imaging designs, manufactures, and markets medical imaging systems for the diagnosis of breast cancer.

Hologic, under the terms of the agreement, has agreed to purchase the mammography intellectual property for a cash purchase price of US$32 million. "Expanding our market share in women's health is a key element in the growth of our company,” said Jack Cumming, chairman and CEO, Hologic. "The acquisition of these technologies is consistent with the company's strategy of looking to the future and building upon our established technology road map. Through a planned approach of ongoing technological advances and acquiring some of the best intellectual property in the field, Hologic has been able to offer innovative solutions to our customers. We believe this acquisition provides us with additional technical capabilities and customer relationships to further solidify our position of strength in the growing mammography market.”





Related Links:
Hologic
Fischer Imaging
Digital Color Doppler Ultrasound System
MS22Plus
Adjustable Mobile Barrier
M-458
Post-Processing Imaging System
DynaCAD Prostate
Portable X-ray Unit
AJEX140H

Channels

Nuclear Medicine

view channel
Image: This artistic representation illustrates how the drug candidate NECT-224 works in the human body (Photo courtesy of HZDR/A. Gruetzner)

Radiopharmaceutical Molecule Marker to Improve Choice of Bladder Cancer Therapies

Targeted cancer therapies only work when tumor cells express the specific molecular structures they are designed to attack. In urothelial carcinoma, a common form of bladder cancer, the cell surface protein... Read more

Imaging IT

view channel
Image: The new Medical Imaging Suite makes healthcare imaging data more accessible, interoperable and useful (Photo courtesy of Google Cloud)

New Google Cloud Medical Imaging Suite Makes Imaging Healthcare Data More Accessible

Medical imaging is a critical tool used to diagnose patients, and there are billions of medical images scanned globally each year. Imaging data accounts for about 90% of all healthcare data1 and, until... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.